Medpace Holdings (MEDP) Cash from Operations (2015 - 2026)

Medpace Holdings has reported Cash from Operations for 12 years, with the latest figure at 151788000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 20.62% year-over-year to 151788000.0; the trailing twelve-month figure through Mar 2026 stood at 739175000.0 (up 27.01% YoY), and the FY2025 full-year result was 713223000.0, up 17.15% from the prior year.
• Cash from Operations for Q1 2026 stood at 151788000.0, down from 192652000.0 in the prior quarter.
• The five-year high for Cash from Operations was 246209000.0 in Q3 2025, with the low at 46256000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 135014705.88 across 5 years, with a median of 136684000.0 in 2022.
• The largest YoY upside for Cash from Operations was 92.8% in 2022 against a maximum downside of 19.3% in 2022.
• Medpace Holdings' Cash from Operations stood at 136684000.0 in 2022, then advanced by 14.42% to 156395000.0 in 2023, then climbed by 21.91% to 190666000.0 in 2024, then grew by 1.04% to 192652000.0 in 2025, then dropped by 21.21% to 151788000.0 in 2026.
• The last three Cash from Operations figures came in at 151788000.0 (Q1 2026), 192652000.0 (Q4 2025), and 246209000.0 (Q3 2025), per Business Quant data.